<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical blood conservation: Intraoperative blood salvage</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical blood conservation: Intraoperative blood salvage</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical blood conservation: Intraoperative blood salvage</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michele Heath, LP, CCP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Aryeh Shander, MD, FCCM, FCCP, FASA</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven Kleinman, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer S Tirnauer, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1756781374"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Surgical blood conservation techniques reduce patient exposure to allogeneic blood during and after surgery. Techniques include preoperative autologous donation, intraoperative hemodilution, and surgical blood salvage (ie, cell salvage).</p><p>This topic will review the indications, benefits, and potential complications of intraoperative blood salvage. The other perioperative blood conservation techniques are discussed separately. (See  <a class="medical medical_review" href="/d/html/7930.html" rel="external">"Surgical blood conservation: Preoperative autologous blood donation"</a> and  <a class="medical medical_review" href="/d/html/7936.html" rel="external">"Surgical blood conservation: Acute normovolemic hemodilution"</a>.)</p><p class="headingAnchor" id="H380732602"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>Blood salvage can be used throughout the surgical procedure to rapidly provide a large volume of washed autologous red blood cell (RBC) units. Indications include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Major surgical procedures</strong> <strong>with anticipated significant blood loss </strong>– There are no good data to define the estimated blood loss at which blood salvage is appropriate. The rationale is strong for an estimated blood loss of 1000 mL and reasonable for some patients with estimated blood loss of 500 to 750 mL. This discussion uses a threshold of &gt;750 mL; however, the value is only an estimate, different thresholds may apply to different patients, and the exact threshold is individualized.</p><p></p><p class="bulletIndent1">We recommend intraoperative blood salvage (also known as blood recovery) for most surgical procedures having a high likelihood of significant blood loss (eg, &gt;750 mL), particularly if transfusion of allogeneic blood is likely  (<a class="graphic graphic_algorithm graphicRef142978" href="/d/graphic/142978.html" rel="external">algorithm 1</a>). This recommendation is based on evidence that allogeneic transfusion and associated complications can potentially be avoided or minimized when intraoperative blood salvage is used, with a low incidence of adverse events [<a href="#rid1">1-4</a>]. This technique is used effectively in various elective and emergency major surgical procedures, including cardiac, major vascular, major orthopedic, trauma, transplantation, and selected urologic, gynecologic, neurosurgical, and plastic surgical procedures. (See <a class="local">'Benefits'</a> below and <a class="local">'Potential complications'</a> below.)</p><p></p><p class="bulletIndent1">Decisions regarding the use of intraoperative blood salvage in cases with moderate anticipated blood loss (eg, 500 to 750 mL) are individualized, considering factors such as known preoperative or intraoperative factors that influence the likelihood of transfusion, nature of any relative contraindications, and availability of crossmatch-compatible allogeneic blood. (See <a class="local">'Relative contraindications'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients who decline allogeneic blood</strong> – Intraoperative blood salvage is also used for patients who will not accept allogeneic blood, provided there are no absolute contraindications. The technique is usually acceptable to Jehovah's Witnesses who decline allogeneic blood and is nearly always used after discussion with such patients if there are no absolute contraindications [<a href="#rid5">5-7</a>] (see <a class="local">'Absolute contraindications'</a> below). Although specific beliefs vary, requirements for acceptance may include assurance that the blood does not leave the operating room for processing and/or that the blood remains continuously connected to the patient via intravenous tubing. (See  <a class="medical medical_review" href="/d/html/7927.html" rel="external">"Approach to the patient who declines blood transfusion", section on 'Jehovah's Witnesses'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Situations when crossmatch-compatible blood cannot be obtained </strong>–<strong> </strong>Intraoperative blood salvage may be lifesaving in patients with a rare blood type or multiple RBC alloantibodies when crossmatch-compatible blood cannot readily be obtained. However, patients should never be denied potentially life-saving transfusion due to cross-matching difficulties, since emergency release blood is always available and is generally well-tolerated. (See  <a class="medical medical_review" href="/d/html/7953.html" rel="external">"Pretransfusion testing for red blood cell transfusion", section on 'Emergency release blood for life-threatening anemia or bleeding'</a>.)</p><p></p><p class="headingAnchor" id="H3001843325"><span class="h1">BENEFITS</span><span class="headingEndMark"> — </span>Intraoperative blood salvage can be effective in avoiding or reducing allogeneic red blood cell (RBC) transfusion, with its attendant costs and risks [<a href="#rid1">1,2</a>]. (See  <a class="medical medical_review" href="/d/html/7948.html" rel="external">"Indications and hemoglobin thresholds for RBC transfusion in adults", section on 'Risks and complications of transfusion'</a>.)</p><p>Potential benefits include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reduced need for transfusion of allogeneic RBCs </strong>–<strong> </strong>Evidence supporting intraoperative blood salvage comes from randomized trials and observational studies demonstrating that blood salvage reduces the need for allogenic RBC transfusion with certain high blood loss procedures [<a href="#rid1">1,2,8-34</a>]. A 2023 meta-analysis of 106 randomized trials (14,528 patients) identified a benefit of blood salvage in reducing allogeneic RBC transfusion in the following [<a href="#rid1">1</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiovascular surgery without cardiopulmonary bypass (CPB) (Relative risk [RR] 0.82, 95% CI 0.69-0.97; 3 trials with 169 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Cardiovascular surgery with CPB (RR 0.81, 95% CI 0.73-0.89; 29 trials with 2936 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Major orthopedic (hip only) surgery (RR 0.52, 95% CI 0.38-0.72; 14 trials with 1641 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Major orthopedic (knee only) surgery (RR 0.49, 95% CI 0.37-0.66; 21 trials with 2214 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Orthopedic spine surgery (RR 0.44, 95% CI 0.31-0.63; 3 trials with 194 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Mixed orthopedic surgical procedures (RR 0.64, 95% CI 0.45-0.90; 11 trials with 4011 patients)</p><p></p><p class="bulletIndent1">However, certainty regarding evidence of efficacy ranged from low to moderate because of marked heterogeneity among studies due to differences in methodology, type of surgery, blood loss, and transfusion behavior. Also, efficacy of blood salvage was inconclusive in vascular, cancer, and obstetrical surgical procedures in this meta-analysis [<a href="#rid1">1</a>]. An earlier 2010 meta-analysis in patients undergoing orthopedic and cardiovascular procedures noted similar results for use of blood salvage compared with controls (risk of transfusion, 30 versus 51 percent; absolute risk reduction 21 percent, 95% CI 15-26 percent; RR 0.62, 95% 0.55-0.70; 67 trials with 6025 patients) [<a href="#rid2">2</a>]. Adverse effects were not increased by the use of blood salvage in either meta-analysis [<a href="#rid1">1,2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Provision of more RBC units than other blood conservation techniques</strong> – Intraoperative blood salvage complements other methods for autologous blood conservation. It can potentially deliver many more units of RBCs than intraoperative acute normovolemic hemodilution, which generally only provides 1 to 3 units of autologous blood [<a href="#rid35">35,36</a>]. (See  <a class="medical medical_review" href="/d/html/7936.html" rel="external">"Surgical blood conservation: Acute normovolemic hemodilution"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Possible time and cost savings </strong>– Intraoperative blood salvage is usually done in the operating room without direct involvement of the transfusion service and also eliminates the need for the patient to provide autologous donations. Thus, intraoperative salvage may save the patient and the blood collection facility time. Cost savings may apply in cardiac cases, where the perfusionist handles the cell saver. In other procedures, cost may be greater due to the need for cell saver equipment and additional personnel in the operating room.</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>There are both absolute and relative contraindications to the use of intraoperative blood salvage [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H24963458"><span class="h2">Absolute contraindications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presence of contraindicated fluids</strong> – Salvaged blood must never be used when solutions that would be toxic with intravascular administration could come into contact with the salvaged blood. Examples include antibiotic irrigation or <a class="drug drug_general" data-topicid="113931" href="/d/drug information/113931.html" rel="external">hydrogen peroxide</a>, alcohol, or povidone-iodine solutions. Also, salvaged blood must never be mixed with hypotonic fluids such as sterile water because this will cause hemolysis [<a href="#rid21">21,37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Admixture with hemostatic products or bone cement </strong>– Suctioned blood from the surgical field cannot be used when there is any potential for simultaneous collection of biologic hemostatic products such as <a class="drug drug_general" data-topicid="10285" href="/d/drug information/10285.html" rel="external">topical thrombin</a>, fibrin glue, or microfibrillar bovine collagen-based products. Examples are Avitene, Actifoam Collagen Sponge, Ultrafoam Sponge, Instat, and Helitene. Although not specifically studied, topical (or intravenous) <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a> is commonly used during surgical cases employing cell salvage and is not contraindicated. (See  <a class="medical medical_review" href="/d/html/15069.html" rel="external">"Overview of topical hemostatic agents and tissue adhesives"</a>.)</p><p></p><p class="bulletIndent1">Similarly, blood salvage cannot be used if there is any chance of admixture with the bone cement methyl methacrylate [<a href="#rid21">21,37</a>].</p><p></p><p class="headingAnchor" id="H24963465"><span class="h2">Relative contraindications</span><span class="headingEndMark"> — </span>The following relative contraindications are controversial because there is no compelling evidence to suggest an association with adverse outcomes. Use of intraoperative blood salvage for patients with these diagnoses has been expanded without clear-cut negative consequences [<a href="#rid37">37</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial infections</strong> – Decisions about using intraoperative blood salvage in patients with bacterial infections are made on a case-by-case basis, with consideration of relative risks and benefits for the individual patient, and with informed consent [<a href="#rid4">4</a>]. These include the potential infection risk of this technique compared with the known risk of postoperative infection after transfusion of allogeneic blood [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/d/html/7948.html" rel="external">"Indications and hemoglobin thresholds for RBC transfusion in adults", section on 'Risks and complications of transfusion'</a> and  <a class="medical medical_review" href="/d/html/3805.html" rel="external">"Transfusion-transmitted bacterial infection"</a>.)</p><p></p><p class="bulletIndent1">Bacterial contamination of the surgical wound has traditionally been a contraindication to intraoperative blood salvage. However, there are no reports of bacteremia and sepsis in otherwise healthy people who were transfused in the intraoperative period with salvaged blood containing bacteria. Small studies support the appropriateness of more liberal use of intraoperative blood salvage in this setting. In a case series that included 11 hemorrhaging trauma patients with enterically contaminated wounds, rapid access to a large volume of autologous blood for reinfusion was potentially lifesaving; no patient developed intra-abdominal sepsis, and no deaths were reported [<a href="#rid39">39</a>]. A 2015 systematic review in emergency abdominal or thoracic trauma surgery noted no difference in sepsis (measured by blood cultures) or mortality in the blood salvage group compared with the control group receiving allogeneic blood (one trial; n = 44) [<a href="#rid8">8</a>]. A retrospective study of clinical outcomes in 36 patients who received salvaged blood during cardiac surgery noted no clinical sequelae in the third of patients transfused with blood containing bacteria or endotoxin [<a href="#rid40">40</a>]. In another retrospective study, cell salvage was used during cardiac surgery in patients with endocarditis without clinically important adverse consequences [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1">Reasons for the absence of adverse consequences of blood salvage include use of broad-spectrum antibiotics in surgical patients, the practice of irrigating surgical wounds before resuming salvage procedures when contamination occurs, and the thorough washing and filtration used to process salvaged intraoperative blood [<a href="#rid21">21</a>]. Although processing blood via a blood salvage system and then filtering it using a leukocyte reduction filter does not completely sterilize it, a 98 to 100 percent reduction in a variety of bacterial organisms has been demonstrated [<a href="#rid42">42,43</a>]. (See <a class="local">'Technology and procedural steps'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Active malignancy</strong> – Decisions about using intraoperative blood salvage in patients with active malignancy are made on a case-by-case basis, with consideration of factors such as the risk of major intraoperative bleeding, the need for transfusion, the availability of allogeneic blood, and informed patient consent [<a href="#rid4">4</a>]. In a 2012 systematic review that included 10 observational studies, patients who received salvaged autologous blood during oncology surgery did not have a higher incidence of cancer recurrence or metastasis development than those receiving allogeneic blood [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1">The successful use of intraoperative blood salvage in cancer surgery supports more liberal use of the technique in patients with active malignancy [<a href="#rid44">44-47</a>].</p><p></p><p class="bulletIndent1">Malignant cells have been observed in shed blood collected intraoperatively, and extensive cell washing does not remove these cells [<a href="#rid48">48</a>]. However, leukocyte reduction filters have been shown to remove tumor cells from salvaged blood, similar to their ability to remove white blood cells [<a href="#rid46">46,48-53</a>]. (See <a class="local">'Reinfusion'</a> below.)</p><p></p><p class="headingAnchor" id="H4202647639"><span class="h2">Areas of uncertainty</span><span class="headingEndMark"> — </span>Intraoperative blood salvage has been used successfully in the following settings, with continuing research to clarify its risks and benefits [<a href="#rid4">4,21,37,54,55</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstetrics</strong> – Blood salvage, if available, can be helpful in managing patients at risk for postpartum hemorrhage (PPH) during cesarean birth, when patients decline allogeneic blood, or when autologous or crossmatched allogeneic blood is not available [<a href="#rid54">54-60</a>]. Preoperative planning for its use is prudent in obstetric patients at high risk for significant PPH (eg, placenta accreta) [<a href="#rid4">4,61</a>]. Blood salvage in this setting is discussed separately. (See  <a class="medical medical_review" href="/d/html/6712.html" rel="external">"Postpartum hemorrhage: Management approaches requiring laparotomy", section on 'Role of intraoperative cell salvage'</a>.)</p><p></p><p class="bulletIndent1">In some centers, blood salvage is used routinely for patients undergoing cesarean birth, or in patients who develop abnormal bleeding during the procedure [<a href="#rid61">61,62</a>]. In this setting, unique hazards include the possibility of aspiration of amniotic fluid or hemostatic agents together with blood in the surgical field, although the washing process minimizes these risks. (See <a class="local">'Washing'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemoglobinopathies</strong> – There is uncertainty regarding the safety of intraoperative blood salvage for patients with sickle cell disease (eg, theoretical risk of increased sickling) or thalassemia (eg, theoretical risk of increased hemolysis) [<a href="#rid21">21,37,63</a>]. (See  <a class="medical medical_review" href="/d/html/141385.html" rel="external">"Perioperative management of adults with sickle cell disease or thalassemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cold agglutinin disease</strong> – There is uncertainty regarding the safety of intraoperative blood salvage for patients with cold agglutinin disease, depending on the thermal amplitude of the autoantibody and the temperature of the operating room. If intraoperative blood salvage is used in a patient with known cold agglutinin disease, the reinfused blood should be passed through a blood warmer. (See  <a class="medical medical_review" href="/d/html/7084.html" rel="external">"Cold agglutinin disease", section on 'Cold avoidance'</a>.)</p><p></p><p class="headingAnchor" id="H2315052053"><span class="h1">POTENTIAL COMPLICATIONS</span><span class="headingEndMark"> — </span>In one multicenter retrospective review of the records for 33,351 patients receiving intraoperative salvaged blood, only two adverse events were identified (one patient with acute tachycardia, hypertension, dyspnea, and rigors; a second patient with acute hypotension and dyspnea) [<a href="#rid3">3</a>]. There were no deaths.</p><p>Although transfusion of autologous salvaged red blood cell (RBC) units avoids the risk of allergic reactions or alloimmunization, other potential complications are the same as those associated with transfusion of allogeneic blood including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coagulopathy </strong>– Since intraoperative blood salvage replaces only RBCs, dilution of clotting factors can result in clinical coagulopathy and may be a challenging problem accompanying significant blood loss (eg, &gt;1000 mL) after replacement solely by reinfusion of salvaged RBCs without plasma or platelets [<a href="#rid64">64,65</a>].</p><p></p><p class="bulletIndent1">Using viscoelastic testing with rotational thromboelastometry (ROTEM) measurements, one study noted that salvaged blood transfusion exceeding 18.5 percent of a patient's whole blood volume<strong> </strong>decreased the maximum clot firmness of fibrinogen assay (FIBTEM-MCF), with potentially impaired coagulation function [<a href="#rid66">66</a>]. However, decisions to administer other blood components (plasma, platelets, Cryoprecipitate) are based on testing for hemostatic function and the specific intraoperative context. (See  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Intraoperative diagnostic testing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transfusion-associated circulatory overload</strong> – Pulmonary edema due to transfusion-associated circulatory overload (TACO) may occur, especially in patients with compromised cardiac function. TACO may occur more frequently in surgical settings where large volumes of fluid and blood are administered. (See  <a class="medical medical_review" href="/d/html/7919.html" rel="external">"Transfusion-associated circulatory overload (TACO)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infection</strong> – As with transfusion of any blood component, the risk of transfusion-transmitted bacterial infection is a possibility [<a href="#rid65">65</a>]. (See  <a class="medical medical_review" href="/d/html/3805.html" rel="external">"Transfusion-transmitted bacterial infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Air embolism</strong> – Blood salvage machines have the ability to pump massive amounts of air into the reinfusion bag [<a href="#rid67">67,68</a>]. Safety measures and air detection have been added to most cell recovery equipment. If these are not present in older equipment, safeguards to avoid air embolism include [<a href="#rid68">68,69</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transferring the blood into a separate bag.</p><p class="bulletIndent2"><span class="glyph">•</span>Disconnecting the bag from the blood salvage equipment before giving it back to the patient.</p><p></p><p class="bulletIndent1">Other standard safety precautions to avoid air embolism are also employed, including removing residual air from the bag, avoiding use of "pressure bags" to increase the reinfusion rate, and using inline air detectors when an infusion pump is used. (See  <a class="medical medical_review" href="/d/html/8263.html" rel="external">"Air embolism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Embolism of microaggregates or fat </strong>– Embolism of microaggregates consisting of white blood cell and platelet debris in salvaged blood is preventable by use of a 40-micron microaggregate filter for reinfusion. This is standard practice in blood salvage programs, in addition to RBC washing. Although fat embolism is also possible, this is preventable by extra washing and/or use of a leukocyte-reducing filter [<a href="#rid70">70</a>]. (See  <a class="medical medical_review" href="/d/html/1602.html" rel="external">"Fat embolism syndrome"</a>.)</p><p></p><p class="headingAnchor" id="H5847575"><span class="h1">TECHNOLOGY AND PROCEDURAL STEPS</span><span class="headingEndMark"> — </span>The intraoperative blood salvage machine (commonly referred to as a "cell saver" or "cell recovery device") separates, concentrates, and washes salvaged red blood cells (RBCs). Several steps are involved  (<a class="graphic graphic_figure graphicRef100237" href="/d/graphic/100237.html" rel="external">figure 1</a>) [<a href="#rid4">4,21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Suctioning of shed blood from the surgical field and addition of an anticoagulant</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Centrifugation to separate the RBCs from platelets and plasma, concentrate the RBC product, and remove some of the anticoagulant</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Washing of RBCs (to remove the remaining anticoagulant, free hemoglobin, activated thrombogenic substances, and cellular stroma)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eventual reinfusion to the patient</p><p></p><p class="headingAnchor" id="H3738335453"><span class="h2">Aspiration of blood from the surgical field</span><span class="headingEndMark"> — </span>Intraoperative cell salvage starts with aspiration of shed blood through a suction wand as it collects in the surgical field or is squeezed out from blood-soaked surgical gauze pads [<a href="#rid71">71</a>].</p><p>As it is aspirated, the blood is mixed with an anticoagulant (typically heparin) to prevent clotting of the blood before reinfusion [<a href="#rid21">21</a>]. Typically, heparin in <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> with a concentration of approximately 30,000 units/L is used. This solution is slowly and automatically added to the aspirated blood at a rate of 15 mL per 100 mL of collected blood [<a href="#rid21">21</a>]. During subsequent washing of the collected blood, all but a trace of heparin is removed [<a href="#rid21">21,72</a>].</p><p>Citrate is another anticoagulant that may be used. If there is concern about heparin-induced thrombocytopenia (HIT), a citrate-based anticoagulant/preservative solution (eg, citrate-phosphate-dextrose [CPD] or citrate-phosphate-dextrose-adenine [CPD-A]) should be used instead of heparin. Citrate-containing solutions are administered at a rate of 15 mL per 100 mL of collected blood [<a href="#rid21">21</a>].</p><p>Citrate is rapidly metabolized by the liver after transfusion, unless there is severe liver disease or hypoperfusion/shock. Therefore, iatrogenic anticoagulation is unlikely with intraoperative blood salvage. In patients with advanced liver disease who receive a large volume of salvaged blood, it is helpful to monitor calcium levels to detect hypocalcemia if citrate is used as the anticoagulant [<a href="#rid34">34,73</a>]. If there is concern about citrate-induced hypocalcemia (eg, due to impaired liver function, changes consistent with hypocalcemia on the electrocardiogram, or a low measured ionized calcium level), intravenous <a class="drug drug_general" data-topicid="9186" href="/d/drug information/9186.html" rel="external">calcium chloride</a> or <a class="drug drug_general" data-topicid="9190" href="/d/drug information/9190.html" rel="external">calcium gluconate</a> can be administered. (See  <a class="medical medical_review" href="/d/html/7939.html" rel="external">"Practical aspects of red blood cell transfusion in adults: Storage, processing, modifications, and infusion", section on 'Anticoagulant-preservative (A-P) solutions'</a>.)</p><p class="headingAnchor" id="H2977552016"><span class="h2">Centrifugation to concentrate RBCs</span><span class="headingEndMark"> — </span>The aspirated blood is collected in a sterile, filtered collection reservoir until the amount is sufficient for processing (typically 375 to 750 mL). The blood is then pumped into the centrifuge bowl where the RBCs are separated and concentrated to a hemoglobin concentration as high as 18 g/dL, while plasma, platelets, and waste components are sent to a waste bag  (<a class="graphic graphic_figure graphicRef100237" href="/d/graphic/100237.html" rel="external">figure 1</a>). This reduces the total fluid volume administered to the patient.</p><p></p><p>Blood salvage devices can process a full reservoir of blood in approximately three minutes, resulting in 55 to 250 mL of RBCs with hemoglobin concentration as high as 18 g/dL [<a href="#rid21">21,74</a>]. A "partial bowl" that is at least one-half filled with RBCs (eg, insufficient blood to process a full bowl) can be processed if necessary, but the resulting hemoglobin concentration will be &lt;18 g/dL.</p><p class="headingAnchor" id="H965854587"><span class="h2">Washing</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standard washing process </strong>–<strong> </strong>Since salvaged blood has a high concentration of free hemoglobin (due to hemolysis), inflammatory mediators, and other cellular debris, standard procedure is to wash the blood with an isotonic solution (usually normal [0.9 percent] <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>) [<a href="#rid21">21</a>]. In one study, use of a balanced bicarbonate buffered solution (Balsol) resulted in fewer acid-base and electrolyte derangements than normal saline [<a href="#rid75">75</a>]. Some centers change to a balanced electrolyte solution (eg, PlasmaLyte-A) only after administration of a large volume of normal saline (eg, after approximately 1500 mL of saline is reinfused with 3000 mL of salvaged blood) [<a href="#rid21">21,76</a>].</p><p></p><p class="bulletIndent1">Washing removes plasma and platelets; as a result, all clotting factors are decreased [<a href="#rid77">77</a>]. Thus, patients who receive ≥1000 mL of washed autologous RBCs may develop a dilutional coagulopathy that requires treatment with plasma and/or platelet transfusions. (See  <a class="medical medical_review" href="/d/html/7931.html" rel="external">"Massive blood transfusion", section on 'Approach to volume and blood replacement'</a>.)</p><p></p><p class="bulletIndent1">Overall, the quality of salvaged, washed, autologous RBCs, as measured by posttransfusion RBC survival and enzymatic indices of RBC function, is equivalent, if not superior, to RBCs in allogeneic transfusions [<a href="#rid76">76,78-80</a>].</p><p></p><p class="bulletIndent1">Separation and washing of RBCs with the blood salvage machine removes added anticoagulant and virtually eliminates free hemoglobin, platelets, white blood cells, and cellular stroma products that are potentially thrombogenic. In addition, washing markedly decreases biologic response modifiers such as cell-derived microvesicles and CD40 ligand, with no effect on neutral lipids [<a href="#rid81">81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Double washing process for partial bowls </strong>–<strong> </strong>Double washing is used to process a partial bowl in the reservoir that is at least one-half full of RBCs and is also used in selected orthopedic surgical cases or to process any amount of blood in a patient who declines allogeneic blood.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rare use of salvaged unwashed whole blood </strong>–<strong> </strong>In rare intraoperative settings with extremely rapid sustained blood loss (eg, &gt;500 mL/min), it may be beneficial to use the emergency mode of the blood salvage machine in order to rapidly return the salvaged blood without centrifuging or washing, until control of bleeding can be achieved.</p><p></p><p class="bulletIndent1">Returning whole blood in this setting allows the blood to be almost immediately available for reinfusion and may preserve some clotting factors and platelets. However, the risks and disadvantages of infusing unwashed whole blood are significant [<a href="#rid82">82,83</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The anticoagulant that was added to the blood is not removed and may increase bleeding risk.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The reinfused platelets may be dysfunctional after being suctioned from the surgical field [<a href="#rid84">84</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombogenic substances (eg, inflammatory mediators and microaggregates consisting of white blood cell and platelet debris) may be introduced.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The hemoglobin concentration of whole blood is lower (range: 7 to 9 g/dL or lower, depending on the hemoglobin level in the aspirated blood) compared with a typical concentration of 16 to 18 g/dL in centrifuged, washed blood.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There may be significant amounts of free hemoglobin due to hemolysis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fat may be present in the unwashed product, with increased risk of fat embolism.</p><p></p><p class="bulletIndent1">In these rare emergency circumstances, it is particularly important to use a 40-micron microaggregate filter for reinfusion. Also, the anticoagulant drip rate is increased due to the larger blood volume being processed. In such cases, protamine may be administered to neutralize the heparin in the reinfused unwashed blood to avoid coagulopathy. Ideally, the protamine dose is determined using a point-of-care heparin-protamine titration assay. If this is not available, an empiric dosing strategy may be used basing a calculated protamine dose on the amount of heparin that had been administered. Also, activated clotting time (ACT) values are typically obtained to determine adequacy of anticoagulation reversal. (See  <a class="medical medical_review" href="/d/html/140293.html" rel="external">"Protamine: Administration and management of adverse reactions during cardiovascular procedures"</a>.)</p><p></p><p class="headingAnchor" id="H1596598037"><span class="h2">Reinfusion</span><span class="headingEndMark"> — </span>The processed RBC units are pumped from the centrifuge bowl into a blood salvage bag for reinfusion. Reinfusion is typically instituted as soon as the washed RBCs are available, but it may be delayed for up to six hours if not clinically indicated at the moment of preparation (eg, in a clinically hypervolemic patient) [<a href="#rid21">21</a>]. A filter is used during reinfusion:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microaggregate filter</strong> – A 40-micron microaggregate filter is installed between the blood salvage bag and the patient to filter the final blood product as it is reinfused into the patient [<a href="#rid85">85</a>].</p><p></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Leukocyte reduction filter</strong> – Although not routinely used because of cost and poor flow due to clogging, a leukocyte reduction filter is an alternative to a microaggregate filter when it is desirable to achieve optimal removal of bacteria, cancer cells, fat particles, or amniotic fluid [<a href="#rid4">4,56,70</a>] (see <a class="local">'Relative contraindications'</a> above and <a class="local">'Areas of uncertainty'</a> above). This type of filter must be changed after infusion of each 500 mL of blood [<a href="#rid21">21</a>]. Typically, leukocyte-reduced products have &lt;1x10<sup>6</sup> leukocytes/mL, corresponding to approximately 99 percent leukocyte reduction [<a href="#rid86">86,87</a>]. Other components such as platelets can also adhere to these filters, but at least 85 percent of RBCs pass through the filter and into the patient. Polyester or polyamide filters commonly used in blood salvage have a 40-micron pore size and promote relatively selective adhesion of negatively charged leukocytes via three passive mechanisms (blocking, bridging, and interception) and one active mechanism (adhesion). Adhesion-based filters are the most efficient, allowing &gt;99.9 percent leukocyte reduction [<a href="#rid88">88,89</a>]. Technical specifications of leukoreduction filters are discussed separately. (See  <a class="medical medical_review" href="/d/html/7939.html" rel="external">"Practical aspects of red blood cell transfusion in adults: Storage, processing, modifications, and infusion", section on 'Pre-storage leukoreduction'</a>.)</p><p></p><p class="headingAnchor" id="H277616159"><span class="h2">Storage and handling</span><span class="headingEndMark"> — </span>Blood collected by intraoperative blood salvage may be stored either at room temperature for up to six hours or at 1 to 6°C for up to 24 hours if it is collected under aseptic conditions with a device that provides washing, provided that cold storage starts within six hours of initiating collection. Such stored blood must be properly labeled. Minimum labeling requirements include the patient's name and identifying number, the component name, the statement "For Autologous Use Only," and the expiration date and time.</p><p>Blood collected by cell salvage is generally reinfused rather than discarded.</p><p>Blood collected by intraoperative salvage should <strong>never be transfused</strong> <strong>to any patient other than the one from whom it was collected</strong> [<a href="#rid90">90</a>].</p><p class="headingAnchor" id="H1161740497"><span class="h1">ESTABLISHING A BLOOD SALVAGE PROGRAM</span><span class="headingEndMark"> — </span>The Association for the Advancement of Blood &amp; Biotherapies (AABB) Standards for Perioperative Autologous Blood Collection and Administration recommend that hospitals with intraoperative blood salvage programs and blood centers providing the service should establish written policies and procedures for proper collection, labeling, and storage of the collected blood [<a href="#rid69">69</a>]. The clinician responsible for the program should regularly review all policies and procedures. Periodic quality control testing of collected blood is recommended to ensure that collection equipment and techniques result in an aseptic blood product.</p><p>Guidelines and training are essential for the quality assurance of intraoperative blood salvage [<a href="#rid4">4</a>]; this has been described in an editorial as a "largely unregulated cottage industry" [<a href="#rid91">91</a>]. The technique can be performed by a perfusionist who may be available if cardiopulmonary bypass is also necessary for the surgical case, or by a cross-trained operating room employee (eg, anesthesia technician). Cross-training employees as blood salvage technicians might be more economical than using an outsourced specialist service when the caseload exceeds 55 cases per year [<a href="#rid92">92</a>].</p><p class="headingAnchor" id="H1821390135"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/120167.html" rel="external">"Society guideline links: Transfusion and patient blood management"</a>.)</p><p class="headingAnchor" id="H4033979"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications </strong>– For most patients undergoing a surgical procedure anticipated to have a high likelihood of significant blood loss (eg, &gt;750 mL), we recommend intraoperative blood salvage (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>), particularly if transfusion of allogeneic blood is likely. This is based on clinical trial evidence demonstrating that blood salvage reduces the need for allogeneic red blood cell (RBC) transfusion with a low incidence of adverse events. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent1">The technique is also used for patients who will not accept allogeneic blood, provided no absolute contraindications exist. (See  <a class="medical medical_review" href="/d/html/7927.html" rel="external">"Approach to the patient who declines blood transfusion"</a>.)</p><p></p><p class="bulletIndent1">For patients undergoing surgery with moderate anticipated blood loss (500 to 750 mL), decisions regarding use of intraoperative blood salvage are individualized considering factors such as known preoperative or intraoperative factors that influence the likelihood of transfusion, nature of any relative contraindications, and availability of crossmatch-compatible allogeneic blood  (<a class="graphic graphic_algorithm graphicRef142978" href="/d/graphic/142978.html" rel="external">algorithm 1</a>). (See <a class="local">'Indications'</a> above and <a class="local">'Contraindications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benefits </strong>–<strong> </strong>In addition to reduced need for transfusion of allogeneic blood, potential benefits include provision of more RBC units than other blood conservation techniques and, in some settings, time and cost savings. (See <a class="local">'Benefits'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contraindications</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Absolute</strong> – Absolute contraindications include the presence of hypotonic solutions (eg, sterile water) or toxic substances (eg, alcohol, <a class="drug drug_general" data-topicid="113931" href="/d/drug information/113931.html" rel="external">hydrogen peroxide</a>, or povidone-iodine solution), or when there is a possibility of simultaneous collection of biologic hemostatic agents (microfibrillar collagen-based products, <a class="drug drug_general" data-topicid="10285" href="/d/drug information/10285.html" rel="external">topical thrombin</a>, fibrin glue) or methyl methacrylate (bone cement). Use of topical (or intravenous) <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a> is not a contraindication for cell salvage. (See <a class="local">'Absolute contraindications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Relative</strong> – Relative contraindications include systemic bacterial infection, contamination of the surgical wound, or active malignancy. Decisions for use are individualized. (See <a class="local">'Relative contraindications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Areas of uncertainty </strong>–<strong> </strong>Although used in selected patients with the following conditions, investigation of benefits versus risks is ongoing for those with (see <a class="local">'Areas of uncertainty'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Risk for postpartum hemorrhage during cesarean birth</p><p class="bulletIndent3"><span class="glyph">-</span>Hemoglobinopathies</p><p class="bulletIndent3"><span class="glyph">-</span>Cold agglutinin disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential complications</strong> – Potential complications of blood salvage include some of the same transfusion complications as those associated with allogeneic blood transfusion (eg, dilutional coagulopathy, transfusion-related volume overload, bacterial infection, and embolism of air, cellular microaggregates, or fat), but without the risk of allergic reactions or alloimmunization. (See <a class="local">'Potential complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Technology and processing</strong> – Processing of intraoperative salvaged blood involves  (<a class="graphic graphic_figure graphicRef100237" href="/d/graphic/100237.html" rel="external">figure 1</a>) (see <a class="local">'Technology and procedural steps'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Aspiration of blood</strong> – Shed blood from the surgical field is suctioned and mixed with an anticoagulant (typically heparin). (See <a class="local">'Aspiration of blood from the surgical field'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Centrifugation and washing</strong> – The cell recovery device filters, centrifuges, and washes the aspirated blood to separate and concentrate the RBCs and remove the anticoagulant, free heme, and thrombogenic substances such as cell stroma. Salvaged washed RBCs have the same posttransfusion RBC survival as traditional washed RBC products but lack platelets, white blood cells, and clotting factors. (See <a class="local">'Centrifugation to concentrate RBCs'</a> above and <a class="local">'Washing'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Unwashed whole blood </strong>– In rare situations (eg, extremely rapid sustained blood loss &gt;500 mL/min), salvaged blood may be reinfused without processing. Risks include infusion of residual anticoagulant, dysfunctional platelets, thrombogenic substances, free hemoglobin, and possibly fat that might lead to coagulation abnormalities and/or fat emboli.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reinfusion </strong>– A 40-micron microaggregate filter is used during reinfusion. A leukocyte reduction filter is an alternative if optimal removal of bacteria, cancer cells, fat particles, or amniotic fluid is necessary. (See <a class="local">'Reinfusion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Storage</strong> – Blood collected by intraoperative blood salvage should only be given to the patient from whom it was collected; it should never be transfused to any other patient.<strong> </strong>Salvaged blood may be labeled and stored either at room temperature for up to six hours or at 1 to 6°C for up to 24 hours if collected under aseptic conditions with a device that provides washing and if cold storage begins within six hours of collection. (See <a class="local">'Storage and handling'</a> above.)</p><p></p><p class="headingAnchor" id="H3631260745"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Michael Avidan, MD, who contributed to an earlier version of this topic review.</p><p>The UpToDate editorial staff also acknowledges extensive contributions of Arthur J Silvergleid, MD to earlier versions of this and many other topic reviews.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lloyd TD, Geneen LJ, Bernhardt K, et al. Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery. Cochrane Database Syst Rev 2023; 9:CD001888.</a></li><li><a class="nounderline abstract_t">Carless PA, Henry DA, Moxey AJ, et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; :CD001888.</a></li><li><a class="nounderline abstract_t">DeAndrade D, Waters JH, Triulzi DJ, et al. Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage. Transfusion 2016; 56:2768.</a></li><li><a class="nounderline abstract_t">Klein AA, Bailey CR, Charlton AJ, et al. Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 2018; 73:1141.</a></li><li><a class="nounderline abstract_t">Hughes DB, Ullery BW, Barie PS. The contemporary approach to the care of Jehovah's witnesses. J Trauma 2008; 65:237.</a></li><li><a class="nounderline abstract_t">Nieder AM, Simon MA, Kim SS, et al. Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah's Witnesses. Int Braz J Urol 2004; 30:377.</a></li><li><a class="nounderline abstract_t">Garcia JH, Coelho GR, Feitosa Neto BA, et al. Liver transplantation in Jehovah's Witnesses patients in a center of northeastern Brazil. Arq Gastroenterol 2013; 50:138.</a></li><li><a class="nounderline abstract_t">Li J, Sun SL, Tian JH, et al. Cell salvage in emergency trauma surgery. Cochrane Database Syst Rev 2015; 1:CD007379.</a></li><li><a class="nounderline abstract_t">Brown CV, Foulkrod KH, Sadler HT, et al. Autologous blood transfusion during emergency trauma operations. Arch Surg 2010; 145:690.</a></li><li><a class="nounderline abstract_t">Singbartl G, Held AL, Singbartl K. Ranking the effectiveness of autologous blood conservation measures through validated modeling of independent clinical data. Transfusion 2013; 53:3060.</a></li><li><a class="nounderline abstract_t">Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109:320.</a></li><li><a class="nounderline abstract_t">Raval JS, Nelson JB, Woldemichael E, Triulzi DJ. Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 2012; 52:2590.</a></li><li><a class="nounderline abstract_t">Son M, Evanko JC, Mongero LB, et al. Utility of cell salvage in women undergoing abdominal myomectomy. Am J Obstet Gynecol 2014; 211:28.e1.</a></li><li><a class="nounderline abstract_t">Pasternak J, Nikolic D, Milosevic D, et al. An analysis of the influence of intra-operative blood salvage and autologous transfusion on reducing the need for allogeneic transfusion in elective infrarenal abdominal aortic aneurysm repair. Blood Transfus 2014; 12 Suppl 1:s182.</a></li><li><a class="nounderline abstract_t">Weltert L, Nardella S, Rondinelli MB, et al. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison. Transfusion 2013; 53:790.</a></li><li><a class="nounderline abstract_t">Odak S, Raza A, Shah N, Clayson A. Clinical efficacy and cost effectiveness of intraoperative cell salvage in pelvic trauma surgery. Ann R Coll Surg Engl 2013; 95:357.</a></li><li><a class="nounderline abstract_t">Greenky M, Shaner J, Rasouli MR, et al. Intraoperative blood salvage in revision total hip arthroplasty: who benefits most? J Arthroplasty 2014; 29:1298.</a></li><li><a class="nounderline abstract_t">Kim JM, Kim GS, Joh JW, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int 2013; 26:84.</a></li><li><a class="nounderline abstract_t">Vonk AB, Meesters MI, van Dijk WB, et al. Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital. Transfusion 2014; 54:2608.</a></li><li><a class="nounderline abstract_t">Shenolikar A, Wareham K, Newington D, et al. Cell salvage auto transfusion in total knee replacement surgery. Transfus Med 1997; 7:277.</a></li><li><a class="nounderline abstract_t">Waters JH. Intraoperative blood recovery. ASAIO J 2013; 59:11.</a></li><li><a class="nounderline abstract_t">Nathan M, Tishler B, Gauvreau K, et al. A red cell preservation strategy reduces postoperative transfusions in pediatric heart surgery patients. Paediatr Anaesth 2018; 28:450.</a></li><li><a class="nounderline abstract_t">Meybohm P, Choorapoikayil S, Wessels A, et al. Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA. Medicine (Baltimore) 2016; 95:e4490.</a></li><li><a class="nounderline abstract_t">Cronin JA, Oetgen ME, Gordish-Dressman H, et al. Association between perioperative surgical home implementation and transfusion patterns in adolescents with idiopathic scoliosis undergoing spinal fusion. Paediatr Anaesth 2019; 29:611.</a></li><li><a class="nounderline abstract_t">Geube M, Sale S, Bakdash S, et al. Prepump autologous blood collection is associated with reduced intraoperative transfusions in aortic surgery with circulatory arrest: A propensity score-matched analysis. J Thorac Cardiovasc Surg 2022; 164:1572.</a></li><li><a class="nounderline abstract_t">Neef V, Vo L, Herrmann E, et al. The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery - an observational study in a patient blood management centre. Anaesthesiol Intensive Ther 2021; 53:1.</a></li><li><a class="nounderline abstract_t">Di Rocco C, Tamburrini G, Pietrini D. Blood sparing in craniosynostosis surgery. Semin Pediatr Neurol 2004; 11:278.</a></li><li><a class="nounderline abstract_t">Chanda A, Smith DR, Nanda A. Autotransfusion by cell saver technique in surgery of lumbar and thoracic spinal fusion with instrumentation. J Neurosurg 2002; 96:298.</a></li><li><a class="nounderline abstract_t">Vega RA, Lyon C, Kierce JF, et al. Minimizing transfusion requirements for children undergoing craniosynostosis repair: the CHoR protocol. J Neurosurg Pediatr 2014; 14:190.</a></li><li><a class="nounderline abstract_t">International Hemoglobin Information Center variants list. Hemoglobin 1992; 16:127.</a></li><li><a class="nounderline abstract_t">Couch BR, Kim E, Shrestha K, et al. Utility of Cell Saver in Trauma Compared to Cardiac Surgery. Am Surg 2023; 89:3516.</a></li><li><a class="nounderline abstract_t">Lakha AS, Chadha R, Von-Kier S, et al. Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study. Int J Surg 2023; 109:3078.</a></li><li><a class="nounderline abstract_t">Itano H, Akiyama T, Yoshihara M. Clinical efficacy of intraoperative Cell Saver autologous blood salvage in emergency surgery for massive hemothorax. Indian J Thorac Cardiovasc Surg 2023; 39:359.</a></li><li><a class="nounderline abstract_t">Rajendran L, Lenet T, Shorr R, et al. Should Cell Salvage Be Used in Liver Resection and Transplantation? A Systematic Review and Meta-analysis. Ann Surg 2023; 277:456.</a></li><li><a class="nounderline abstract_t">Williamson KR, Taswell HF, Rettke SR, Krom RA. Intraoperative autologous transfusion: its role in orthotopic liver transplantation. Mayo Clin Proc 1989; 64:340.</a></li><li><a class="nounderline abstract_t">Warnock DF, Davison JK, Brewster DC, et al. Modification of the Haemonetics Cell Saver for optional high flow rate autotransfusion. Am J Surg 1982; 143:765.</a></li><li><a class="nounderline abstract_t">Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 2011; 9:139.</a></li><li><a class="nounderline abstract_t">Dzik WH, Sherburne B. Intraoperative blood salvage: medical controversies. Transfus Med Rev 1990; 4:208.</a></li><li><a class="nounderline abstract_t">Timberlake GA, McSwain NE Jr. Autotransfusion of blood contaminated by enteric contents: a potentially life-saving measure in the massively hemorrhaging trauma patient? J Trauma 1988; 28:855.</a></li><li><a class="nounderline abstract_t">Bland LA, Villarino ME, Arduino MJ, et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardiovasc Surg 1992; 103:582.</a></li><li><a class="nounderline abstract_t">Sponholz C, Sommerfeld O, Moehl C, et al. Intraoperative Cell Savage, Infection and Organ Failure in Infective Endocarditis Patients-A Retrospective Single Center Evaluation. J Clin Med 2023; 12.</a></li><li><a class="nounderline abstract_t">Waters JH, Tuohy MJ, Hobson DF, Procop G. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology 2003; 99:652.</a></li><li><a class="nounderline abstract_t">Wollinsky KH, Oethinger M, Büchele M, et al. Autotransfusion--bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. A randomized controlled study of 40 patients. Acta Orthop Scand 1997; 68:225.</a></li><li><a class="nounderline abstract_t">Waters JH, Yazer M, Chen YF, Kloke J. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 2012; 52:2167.</a></li><li><a class="nounderline abstract_t">Kumar N, Tan JYH, Chen Z, et al. Intraoperative cell-salvaged autologous blood transfusion is safe in metastatic spine tumour surgery: early outcomes of prospective clinical study. Eur Spine J 2023; 32:2493.</a></li><li><a class="nounderline abstract_t">Frietsch T, Steinbicker AU, Horn A, et al. Safety of Intraoperative Cell Salvage in Cancer Surgery: An Updated Meta-Analysis of the Current Literature. Transfus Med Hemother 2022; 49:143.</a></li><li><a class="nounderline abstract_t">Murtha-Lemekhova A, Fuchs J, Ritscher E, Hoffmann K. Effect of Autotransfusion in HCC Surgery on Survival and Recurrence: A Systematic Review and Meta-Analysis. Cancers (Basel) 2022; 14.</a></li><li><a class="nounderline abstract_t">Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol 2014; 21:4330.</a></li><li><a class="nounderline abstract_t">Perseghin P, Viganò M, Rocco G, et al. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang 1997; 72:221.</a></li><li><a class="nounderline abstract_t">Edelman MJ, Potter P, Mahaffey KG, et al. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 1996; 47:179.</a></li><li><a class="nounderline abstract_t">Catling S, Williams S, Freites O, et al. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008; 63:1332.</a></li><li><a class="nounderline abstract_t">Kumar N, Chen Y, Zaw AS, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 2014; 15:e33.</a></li><li><a class="nounderline abstract_t">Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol 2014; 21:2436.</a></li><li><a class="nounderline abstract_t">Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol 2017; 130:e168. Reaffirmed 2023.</a></li><li><a class="nounderline abstract_t">Lim G, Melnyk V, Facco FL, et al. Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage. Anesthesiology 2018; 128:328.</a></li><li><a class="nounderline abstract_t">Goucher H, Wong CA, Patel SK, Toledo P. Cell Salvage in Obstetrics. Anesth Analg 2015; 121:465.</a></li><li><a class="nounderline abstract_t">Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000; 92:1531.</a></li><li><a class="nounderline abstract_t">Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion 2011; 51:2244.</a></li><li><a class="nounderline abstract_t">Yan H, Hu LQ, Wu Y, et al. The Association of Targeted Cell Salvage Blood Transfusion During Cesarean Delivery With Allogeneic Packed Red Blood Cell Transfusions in a Maternity Hospital in China. Anesth Analg 2018; 127:706.</a></li><li><a class="nounderline abstract_t">Practice Guidelines for Obstetric Anesthesia: An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology. Anesthesiology 2016; 124:270.</a></li><li><a class="nounderline abstract_t">Waters JH, Beck S, Yazer MH. How do I perform cell salvage in obstetrics? Transfusion 2019; 59:2199.</a></li><li><a class="nounderline abstract_t">Sullivan IJ, Ralph CJ. Obstetric intra-operative cell salvage: a review of an established cell salvage service with 1170 re-infused cases. Anaesthesia 2019; 74:976.</a></li><li><a class="nounderline abstract_t">Waters JH, Lukauskiene E, Anderson ME. Intraoperative blood salvage during cesarean delivery in a patient with beta thalassemia intermedia. Anesth Analg 2003; 97:1808.</a></li><li><a class="nounderline abstract_t">Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010; 105:401.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*. Anesthesiology 2015; 122:241.</a></li><li><a class="nounderline abstract_t">Son K, Yamada T, Tarao K, et al. Effects of Cardiac Surgery and Salvaged Blood Transfusion on Coagulation Function Assessed by Thromboelastometry. J Cardiothorac Vasc Anesth 2020; 34:2375.</a></li><li><a class="nounderline abstract_t">Linden JV, Kaplan HS, Murphy MT. Fatal air embolism due to perioperative blood recovery. Anesth Analg 1997; 84:422.</a></li><li><a class="nounderline abstract_t">Engelhardt W, Blumenberg D. [Risks and side effects of intraoperative autotransfusion]. Beitr Infusionsther 1991; 28:317.</a></li><li class="breakAll">AABB. Standards for Perioperative Autologous Blood Collection and Administration, 5th ed, 2013.</li><li><a class="nounderline abstract_t">Konig G, Waters JH. Washing and filtering of cell-salvaged blood - does it make autotransfusion safer? Transfus Altern Transfus Med 2012; 12:78.</a></li><li><a class="nounderline abstract_t">Chung YS, Kim HR, Kang H, et al. Fragility of Red Blood Cells Collected Under Different Conditions With a Cell Saver Device. J Cardiothorac Vasc Anesth 2019; 33:1224.</a></li><li><a class="nounderline abstract_t">Kelleher A, Davidson S, Gohil M, et al. A quality assurance programme for cell salvage in cardiac surgery. Anaesthesia 2011; 66:901.</a></li><li><a class="nounderline abstract_t">Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17:R76.</a></li><li><a class="nounderline abstract_t">Gruber M, Breu A, Frauendorf M, et al. Washing of banked blood by three different blood salvage devices. Transfusion 2013; 53:1001.</a></li><li><a class="nounderline abstract_t">Pillay K, Perumal S. Intraoperative Cell Saving: Is the Solution the Actual Problem? J Extra Corpor Technol 2021; 53:62.</a></li><li><a class="nounderline abstract_t">Hansen E, Hansen MP. Reasons against the retransfusion of unwashed wound blood. Transfusion 2004; 44:45S.</a></li><li><a class="nounderline abstract_t">Adam EH, Funke M, Zacharowski K, et al. Impact of Intraoperative Cell Salvage on Blood Coagulation Factor Concentrations in Patients Undergoing Cardiac Surgery. Anesth Analg 2020; 130:1389.</a></li><li><a class="nounderline abstract_t">Ansell J, Parrilla N, King M, et al. Survival of autotransfused red blood cells recovered from the surgical field during cardiovascular operations. J Thorac Cardiovasc Surg 1982; 84:387.</a></li><li><a class="nounderline abstract_t">Valeri CR, Pivacek LE, Gray AD, et al. The safety and therapeutic effectiveness of human red cells stored at -80 degrees C for as long as 21 years. Transfusion 1989; 29:429.</a></li><li><a class="nounderline abstract_t">Shulman G. Quality of processed blood for autotransfusion. J Extra Corpor Technol 2000; 32:11.</a></li><li><a class="nounderline abstract_t">Welsby IJ, Norris PJ, Mauermann WJ, et al. Bedside Allogeneic Erythrocyte Washing with a Cell Saver to Remove Cytokines, Chemokines, and Cell-derived Microvesicles. Anesthesiology 2021; 134:395.</a></li><li><a class="nounderline abstract_t">Matsuda K, Nozawa M, Katsube S, et al. Activation of fibrinolysis by reinfusion of unwashed salvaged blood after total knee arthroplasty. Transfus Apher Sci 2010; 42:33.</a></li><li><a class="nounderline abstract_t">Gäbel J, Hakimi CS, Westerberg M, et al. Retransfusion of cardiotomy suction blood impairs haemostasis: ex vivo and in vivo studies. Scand Cardiovasc J 2013; 47:368.</a></li><li><a class="nounderline abstract_t">Gäbel J, Malm CJ, Radulovic V, et al. Cell saver processing mitigates the negative effects of wound blood on platelet function. Acta Anaesthesiol Scand 2016; 60:901.</a></li><li><a class="nounderline abstract_t">Ramírez G, Romero A, García-Vallejo JJ, Muñoz M. Detection and removal of fat particles from postoperative salvaged blood in orthopedic surgery. Transfusion 2002; 42:66.</a></li><li><a class="nounderline abstract_t">Singh S, Kumar A. Leukocyte depletion for safe blood transfusion. Biotechnol J 2009; 4:1140.</a></li><li><a class="nounderline abstract_t">Jirousková M, Bartunková J, Smetana K Jr, et al. Comparative study of human monocyte and platelet adhesion to hydrogels in vitro - effect of polymer structure. J Mater Sci Mater Med 1997; 8:19.</a></li><li><a class="nounderline abstract_t">Sharma AD, Sreeram G, Erb T, et al. Leukocyte-reduced blood transfusions: perioperative indications, adverse effects, and cost analysis. Anesth Analg 2000; 90:1315.</a></li><li><a class="nounderline abstract_t">Dzik S. Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. Transfus Med Rev 1993; 7:65.</a></li><li><a class="nounderline abstract_t">Uramatsu M, Maeda H, Mishima S, et al. Serious hazards of transfusion: evaluating the dangers of a wrong patient autologous salvaged blood in cardiac surgery. J Cardiothorac Surg 2022; 17:182.</a></li><li><a class="nounderline abstract_t">Weiskopf RB. Erythrocyte salvage during cesarean section. Anesthesiology 2000; 92:1519.</a></li><li><a class="nounderline abstract_t">Szpisjak DF, Potter PS, Capehart BP. Economic analysis of an intraoperative cell salvage service. Anesth Analg 2004; 98:201.</a></li></ol></div><div id="topicVersionRevision">Topic 7937 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37681564" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20393932" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cell salvage for minimising perioperative allogeneic blood transfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27614051" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29989144" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18580506" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The contemporary approach to the care of Jehovah's witnesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15610568" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah's Witnesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23903624" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Liver transplantation in Jehovah's Witnesses patients in a center of northeastern Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25613473" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Cell salvage in emergency trauma surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20644133" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Autologous blood transfusion during emergency trauma operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23656520" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ranking the effectiveness of autologous blood conservation measures through validated modeling of independent clinical data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19608798" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22612661" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24565686" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Utility of cell salvage in women undergoing abdominal myomectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114525" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : An analysis of the influence of intra-operative blood salvage and autologous transfusion on reducing the need for allogeneic transfusion in elective infrarenal abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22882381" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23838500" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical efficacy and cost effectiveness of intraoperative cell salvage in pelvic trauma surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24412146" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Intraoperative blood salvage in revision total hip arthroplasty: who benefits most?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23194351" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24372139" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9510924" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cell salvage auto transfusion in total knee replacement surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23232181" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Intraoperative blood recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29575610" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A red cell preservation strategy reduces postoperative transfusions in pediatric heart surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27495095" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30801879" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Association between perioperative surgical home implementation and transfusion patterns in adolescents with idiopathic scoliosis undergoing spinal fusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33610366" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prepump autologous blood collection is associated with reduced intraoperative transfusions in aortic surgery with circulatory arrest: A propensity score-matched analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33625822" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery - an observational study in a patient blood management centre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15828712" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Blood sparing in craniosynostosis surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11990838" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Autotransfusion by cell saver technique in surgery of lumbar and thoracic spinal fusion with instrumentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24877603" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Minimizing transfusion requirements for children undergoing craniosynostosis repair: the CHoR protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1572804" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : International Hemoglobin Information Center variants list.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36889677" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Utility of Cell Saver in Trauma Compared to Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37402308" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37346430" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical efficacy of intraoperative Cell Saver autologous blood salvage in emergency surgery for massive hemothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35861339" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Should Cell Salvage Be Used in Liver Resection and Transplantation? A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2495389" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Intraoperative autologous transfusion: its role in orthotopic liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7091514" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Modification of the Haemonetics Cell Saver for optional high flow rate autotransfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21251468" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Intra-operative cell salvage: a fresh look at the indications and contraindications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2134631" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Intraoperative blood salvage: medical controversies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3385834" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Autotransfusion of blood contaminated by enteric contents: a potentially life-saving measure in the massively hemorrhaging trauma patient?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1545559" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36615185" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intraoperative Cell Savage, Infection and Organ Failure in Infective Endocarditis Patients-A Retrospective Single Center Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12960550" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Bacterial reduction by cell salvage washing and leukocyte depletion filtration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9246981" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Autotransfusion--bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. A randomized controlled study of 40 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22321196" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Blood salvage and cancer surgery: a meta-analysis of available studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37191676" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Intraoperative cell-salvaged autologous blood transfusion is safe in metastatic spine tumour surgery: early outcomes of prospective clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35813601" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Safety of Intraoperative Cell Salvage in Cancer Surgery: An Updated Meta-Analysis of the Current Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36230760" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effect of Autotransfusion in HCC Surgery on Survival and Recurrence: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25069862" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9228711" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8607229" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19032302" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24384492" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24566859" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Can there be a place for intraoperative salvaged blood in spine tumor surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28937571" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Practice Bulletin No. 183: Postpartum Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29194062" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26197375" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cell Salvage in Obstetrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10839901" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Amniotic fluid removal during cell salvage in the cesarean section patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21446940" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Intraoperative cell salvage in obstetrics: is it a real therapeutic option?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29505447" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The Association of Targeted Cell Salvage Blood Transfusion During Cesarean Delivery With Allogeneic Packed Red Blood Cell Transfusions in a Maternity Hospital in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26580836" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Practice Guidelines for Obstetric Anesthesia: An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31145473" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : How do I perform cell salvage in obstetrics?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30912123" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Obstetric intra-operative cell salvage: a review of an established cell salvage service with 1170 re-infused cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14633564" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Intraoperative blood salvage during cesarean delivery in a patient with beta thalassemia intermedia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20802228" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Cell salvage as part of a blood conservation strategy in anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25545654" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32178956" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effects of Cardiac Surgery and Salvaged Blood Transfusion on Coagulation Function Assessed by Thromboelastometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9024041" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Fatal air embolism due to perioperative blood recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1725646" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : [Risks and side effects of intraoperative autotransfusion].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1725646" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : [Risks and side effects of intraoperative autotransfusion].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24955005" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Washing and filtering of cell-salvaged blood - does it make autotransfusion safer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30655204" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Fragility of Red Blood Cells Collected Under Different Conditions With a Cell Saver Device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21883128" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : A quality assurance programme for cell salvage in cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23601765" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Management of bleeding and coagulopathy following major trauma: an updated European guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22897672" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Washing of banked blood by three different blood salvage devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33814608" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Intraoperative Cell Saving: Is the Solution the Actual Problem?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15585005" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Reasons against the retransfusion of unwashed wound blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32058448" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Impact of Intraoperative Cell Salvage on Blood Coagulation Factor Concentrations in Patients Undergoing Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6981035" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Survival of autotransfused red blood cells recovered from the surgical field during cardiovascular operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2734823" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : The safety and therapeutic effectiveness of human red cells stored at -80 degrees C for as long as 21 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10947618" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Quality of processed blood for autotransfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33503656" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Bedside Allogeneic Erythrocyte Washing with a Cell Saver to Remove Cytokines, Chemokines, and Cell-derived Microvesicles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19932982" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Activation of fibrinolysis by reinfusion of unwashed salvaged blood after total knee arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24040767" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Retransfusion of cardiotomy suction blood impairs haemostasis: ex vivo and in vivo studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27137133" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Cell saver processing mitigates the negative effects of wound blood on platelet function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11896315" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Detection and removal of fat particles from postoperative salvaged blood in orthopedic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19418471" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Leukocyte depletion for safe blood transfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15348837" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Comparative study of human monocyte and platelet adhesion to hydrogels in vitro - effect of polymer structure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10825313" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Leukocyte-reduced blood transfusions: perioperative indications, adverse effects, and cost analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8481601" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Leukodepletion blood filters: filter design and mechanisms of leukocyte removal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35974374" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Serious hazards of transfusion: evaluating the dangers of a wrong patient autologous salvaged blood in cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10839899" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Erythrocyte salvage during cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14693619" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Economic analysis of an intraoperative cell salvage service.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
